Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
BACKGROUND: A EULAR taskforce was convened to develop recommendations for lifestyle behaviours in rheumatic and musculoskeletal diseases (RMDs). The aim of this paper was to review the literature on the relationship between smoking and alcohol consumption with regard to RMD-specific outcomes.
METHODS: Two systematic reviews were conducted to identify systematic reviews and meta-analyses, published between 2013 and 2018, related to smoking and alcohol consumption in seven RMDs: osteoarthritis (OA), rheumatoid arthritis (RA), systemic lupus erythematosus, axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), systemic sclerosis (SSc) and gout. Two additional systematic reviews were performed to identify original longitudinal studies on smoking and alcohol consumption and disease-specific outcomes.
RESULTS: Nine reviews and 65 original studies on smoking as well as two reviews and 14 original studies on alcohol consumption met the inclusion criteria. While most studies were moderate/poor quality, smoking was significantly associated with poorer outcomes: cardiovascular comorbidity; poorer response to RA treatment; higher disease activity and severity in early RA; axSpA radiographic progression. Results were heterogeneous for OA while there was limited evidence for PsA, SSc and gout. Available studies on alcohol mainly focused on RA, reporting a positive association between alcohol intake and radiographic progression. Five studies assessed alcohol consumption in gout, reporting a significant association between the number and type of alcoholic beverages and the occurrence of flares.
CONCLUSION: Current literature supports that smoking has a negative impact on several RMD-specific outcomes and that moderate or high alcohol consumption is associated with increased risk of flares in RA and gout.
Additional Info
-
Authors
Wieczorek M.; Gwinnutt J. M.; Ransay-Colle M.; Balanescu A.; Bischoff-Ferrari H.; Boonen A.; Cavalli G.; de Souza S.; de Thurah A.; Dorner T. E.; Moe R. H.; Putrik P.; Rodriguez-Carrio J.; Silva-Fernandez L.; Stamm T. A.; Walker-Bone K.; Welling J.; Zlatkovic-Svenda M.; Verstappen S. M.; Guillemin F. -
Issue
RMD Open . 2022 Mar;8(1):e002170 -
Published Date
march 2022
Related items
- Mediterranean diet: definitions, health effects and metabolic pathways – evidence and future directions
- Interpreting the Evidence on Wine Consumption and Health: A Narrative Review of the J-Shaped Association and Contemporary Alcohol Guidelines
- Attitudes Toward Cancer and Heart Disease Warning Labels on Alcoholic Beverages in the United States
- Age at first drink below 19 years and all-cause mortality in Chinese older adults: a 10-year prospective cohort study
- Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial